July 15, 2005 — The U.S. Food and Drug Administration (FDA) has approved single- and dual-chamber versions of an implantable cardioverter defibrillator that feature managed ventricular pacing and ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) is celebrating the 20 th anniversary of the introduction of the GORE® VIABAHN® Endoprosthesis, the market-leading stent-graft ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced that the Food and Drug Administration (FDA) has granted indication for the GORE® VIABAHN® Endoprosthesis to treat ...

The investigational device evaluated in the trial, previously known as the GORE ® VIAFORT Vascular Stent, will now be referred to as the GORE ® VIABAHN ® FORTEGRA Venous Stent. CAUTION: ...

The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz., Jan. 6, 2026 ...

FLAGSTAFF, Ariz., W. L. Gore & Associates (Gore) announces that the first patients are now enrolled in the Gore RELINE MAX Clinical Study, a post-approval study to continue to evaluate the GORE® ...

Gore won FDA approval for its VIABAHN VBX endoprosthesis to be used in the iliac arteries, making it the only balloon expandable stent graft having such an indication. It can be used on new or ...

Please provide your email address to receive an email when new articles are posted on . The U.S Food and Drug Administration has granted indication for the Viabahn Endoprosthesis, made by W. L. Gore & ...

The EMBRACE Registry aims to evaluate safety and performance of the GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis when used as a bridging stent with branched and fenestrated endografts in the ...

(MENAFN- PR Newswire) The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease ...